Tumour lysis syndrome in a patient with renal-cell carcinoma treated with sunitinib malate

Lancet. 2007 Jun 9;369(9577):1923-4. doi: 10.1016/S0140-6736(07)60903-9.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged
  • Angiogenesis Inhibitors / adverse effects*
  • Angiogenesis Inhibitors / therapeutic use
  • Carcinoma, Renal Cell / drug therapy*
  • Carcinoma, Renal Cell / pathology
  • Carcinoma, Renal Cell / surgery
  • Clinical Trials as Topic
  • Female
  • Humans
  • Indoles / adverse effects*
  • Indoles / therapeutic use
  • Kidney Neoplasms / drug therapy*
  • Kidney Neoplasms / pathology
  • Kidney Neoplasms / surgery
  • Pyrroles / adverse effects*
  • Pyrroles / therapeutic use
  • Sunitinib
  • Tumor Lysis Syndrome / etiology*
  • Tumor Lysis Syndrome / physiopathology
  • Tumor Lysis Syndrome / therapy

Substances

  • Angiogenesis Inhibitors
  • Indoles
  • Pyrroles
  • Sunitinib